{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:26:04Z","timestamp":1793841964763,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.10.018","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:57:20Z","timestamp":1792231040000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["External Validation of the CARE-BMT and Modified CARE-BMT Scores for Cardiac Event Prediction After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia"],"prefix":"10.1016","author":[{"given":"Arnau","family":"Torrent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Cascos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Baile-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Mart\u00edn","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas Pascual","family":"Casc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Esquirol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Mart\u00edn","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo Jes\u00fas S\u00e1ez","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fern\u00e1ndez-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Dom\u00ednguez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Villar","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Pilar","family":"Gonz\u00e1lez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Torrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Filaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Jurado","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Queralt","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtct.2026.10.018_bib0001","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation","volume":"3","author":"Dul\u00e9ry","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"41","key":"10.1016\/j.jtct.2026.10.018_bib0002","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.jtct.2026.10.018_bib0003","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1182\/bloodadvances.2024013535","article-title":"Cardiac events after allo-HCT in patients with acute myeloid leukemia","volume":"8","author":"Salas","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.018_bib0004","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.30534","article-title":"Cardiomyopathy in patients after posttransplant cyclophosphamide\u2013based hematopoietic cell transplantation","volume":"123","author":"Lin","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jtct.2026.10.018_bib0005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaccao.2023.07.007","article-title":"Cardiovascular events after hematopoietic stem cell transplant","volume":"5","author":"Vasbinder","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"16","key":"10.1016\/j.jtct.2026.10.018_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001220","article-title":"Cardiovascular management of patients undergoing hematopoietic stem cell transplantation: from pretransplantation to survivorship: a scientific statement from the American Heart Association","volume":"149","author":"Hayek","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jtct.2026.10.018_bib0007","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaccao.2021.04.004","article-title":"Post-transplantation cyclophosphamide","volume":"3","author":"Rotz","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"24","key":"10.1016\/j.jtct.2026.10.018_bib0008","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant\u2013related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.jtct.2026.10.018_bib0009","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/bloodadvances.2021005847","article-title":"Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial","volume":"6","author":"Broers","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jtct.2026.10.018_bib0010","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"25","key":"10.1016\/j.jtct.2026.10.018_bib0011","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based Graft-versus-Host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.10.018_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1050994","article-title":"Early vascular endothelial complications after hematopoietic cell transplantation: role of the endotheliopathy in biomarkers and target therapies development","volume":"13","author":"Moreno-Casta\u00f1o","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.018_bib0013","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for blood and marrow transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jtct.2026.10.018_bib0014","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbmt.2014.02.012","article-title":"Late cardiovascular complications after hematopoietic cell transplantation","volume":"20","author":"Chow","year":"2014","journal-title":"Biol Blood Marrow Transplantat"},{"key":"10.1016\/j.jtct.2026.10.018_bib0015","article-title":"Validation of the CARE-BMT score and proposal of a modified risk model with post-transplant cyclofosfamide for predicting early cardiac events after allo-HCT","author":"Torrent-Rodr\u00edguez","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.10.018_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1571678","article-title":"Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC","volume":"16","author":"Pinto","year":"2025","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.018_bib0017","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.018_bib0018","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/bloodadvances.2022008792","article-title":"Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant","volume":"7","author":"P\u00e9rez-Valencia","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.018_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033599","article-title":"Cardiovascular risk stratification of patients undergoing hematopoietic stem cell transplantation: the CARE-BMT risk score","volume":"13","author":"Vasbinder","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtct.2026.10.018_bib0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.jtct.2026.10.018_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1050994","article-title":"Early vascular endothelial complications after hematopoietic cell transplantation: role of the endotheliopathy in biomarkers and target therapies development","volume":"13","author":"Moreno-Casta\u00f1o","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2026.10.018_bib0022","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41409-024-02270-x","article-title":"EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation","volume":"59","author":"Tolosa-Ridao","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.10.018_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104577","article-title":"Role of cardioprotective agents on chemotherapy-induced heart failure: a systematic review and network meta-analysis of randomized controlled trials","volume":"151","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"issue":"13","key":"10.1016\/j.jtct.2026.10.018_bib0024","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.ejca.2013.04.030","article-title":"Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis","volume":"49","author":"Kalam","year":"2013","journal-title":"Eur J Cancer"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.10.018_bib0025","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-198252","article-title":"OPTIMIZE: a phase II study of reduced dose post transplantation cyclophosphamide as GVHD prophylaxis in adult patients with hematologic malignancies receiving HLA-mismatched unrelated donor peripheral blood stem cell transplantation","volume":"144","author":"Auletta","year":"2024","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.jtct.2026.10.018_bib0026","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3390\/cancers17193128","article-title":"Safety of post-transplant cyclophosphamide-based prophylaxis in AML patients with pre-existing cardiac morbidity undergoing allogeneic hematopoietic cell transplantation","volume":"17","author":"Torrent-Rodr\u00edguez","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.jtct.2026.10.018_bib0027","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726008079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726008079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:35:49Z","timestamp":1793838949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726008079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S2666636726008079"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.018","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External Validation of the CARE-BMT and Modified CARE-BMT Scores for Cardiac Event Prediction After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}